Orchard Therapeutics PLC (NASDAQ:ORTX)
| 16.28 Delayed Data As of Dec 07 |  +0.055 / +0.34%Today’s Change | 3.60 Today|||52-Week Range 16.30 | +338.81% Year-to-Date |
Latest ORTX News | Press Releases
No recent news for Orchard Therapeutics PLC.
Today’s Trading
| Previous close | 16.23 |
| Today’s open | 16.22 |
| Day’s range | 16.22 - 16.28 |
| Volume | 1,486 |
| Average volume (3 months) | 198,407 |
| Market cap | $368.7M |
Data as of 3:59pm ET, 12/07/2023
Growth & Valuation
| Earnings growth (last year) | -0.89% |
| Earnings growth (this year) | +82.17% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,251.86% |
| P/E ratio | NM |
| Price/Sales | 2.10 |
| Price/Book | 2.09 |
Financials
| Next reporting date | February 28, 2024 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $22.6M |
| Annual profit (last year) | -$150.6M |
| Net profit margin | -665.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
